Myomo Appoints Dr. Harry Kovelman as Chief Medical Officer
Experienced Physician, Author and Executive to Join Senior Leadership Team
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that Harry Kovelman, MD, is joining the Company as its Chief Medical Officer, effective November 2. In this role, Dr. Kovelman will oversee Myomo’s patient advocacy organization, which helps ensure MyoPro patients’ clinical qualification for the brace and pursues insurance coverage. At Myomo, he will work closely with commercial and government payer organizations to continue to increase patient access to the MyoPro product line.
Recommended AI News: Conversational Marketing Trends: Chatbots Are Still Missing the Human Element of Conversation
Dr. Kovelman brings 25 years of experience in medical devices and pharmaceuticals, including roles as Global Medical Director for Orthopedics at Ottobock Healthcare and Global Medical Affairs Director for Dynasplint Systems. He has also held senior executive roles at Pacira Pharmaceuticals, and Helius Medical Technologies.
Recommended AI News: NUIA Full Focus Launched as a Smart Software for Natural Eye Contact in Video Calls
He is the author of several papers on rehabilitation procedures and has presented at numerous professional conferences on various innovations in healthcare products and services. As a member of the company’s senior leadership team, Dr. Kovelman will lead communicating the Company’s scientific message to the payer community, clinicians, and patients, lead medical activities and educational programs, participate in designing clinical studies of the Company’s products, and manage its Scientific Advisory Board of leading clinical professionals in the fields of rehabilitation medicine, occupational therapy, neurology and pediatric medicine.
Paul R. Gudonis, Myomo CEO, said, “I’m pleased to welcome Dr. Kovelman to Myomo as we continue to expand patient access to our life-changing technology, add to our clinical research, and educate additional medical professionals about the MyoPro product line. I’d also like to thank Dr. Brandon Green who has served in this role for the last four years and is fully supporting the transition in this Chief Medical Officer position.”
Recommended AI News: Starlink Starts Adding Beta Launch Customers for World’s Fastest Satellite Internet Services
Export requirements for Copper scrap Copper recycling regulations Scrap metal processing technology
Recycling Copper cable scrap, Non-ferrous metal recovery, Copper scrap exporters